Thyroid-Stimulating Hormone and Estimated Glomerular Filtration Rate
Sameena Iqbal, Barama Dalila, Davine Yang, Khashayar Rafat Zand and Celena Scheede Bergdahl
Article Type: Original Article | First Published: June 05, 2022
Hypothyroidism has been identified as a comorbidity related to chronic kidney disease (CKD). The retrospective study investigated thyroid function and CKD and assessed the relationship between TSH and urine albumin/creatinine ratio (ACR), the slope of estimated glomerular filtration rate (eGFR), stratified by CKD grades....
Ambulatory Blood Pressure Monitoring in Children with Solitary Kidney
Kanjaporn Sirisomboonlarp, Ankanee Chanakul and Tawatchai Deekajorndech
Article Type: Original Article | First Published: May 11, 2022
Children with a solitary kidney are at risk of developing hypertension due to decreased nephron number with a consequence of hyperfiltration of the remnant. In patients with high-risk conditions, ambulatory blood pressure monitoring (ABPM), which records blood pressure (BP) for 24 hours, is helpful in detecting hypertension. To investigate the prevalence of hypertension in children with solitary kidney using 24-h ABPM and comparing with the office blood pressure (OBP). Twenty-three patients age...
Cocaine Induced ANCA Negative Vasculitis - A Diagnostic Dilemma!
Kunal Bhuta, Kriti Devkota2 and Haris Mobeen
Article Type: Case Series | First Published: April 24, 2022
Cocaine is an addictive stimulant drug. In 2014, about 913,000 Americans met the Diagnostic and Statistical Manual of Mental Disorders criteria for dependence or abuse of cocaine. Approximately 69% of Cocaine has been contaminated with Levamisole. Levamisole has been found to be immunogenic causing anti-neutrophil cyto-plasmic antibody (ANCA)-associated cutaneous vasculitis in 88-100% patients. 24-year-old male with a history of polysubstance abuse including IV drug abuse presented with complain...
Safety and Efficacy of Patiromer in Kidney and Liver Transplant Recipients
Abigail M Servais, PharmD, Eric D Langewisch, MD, Scott G Westphal, MD, and Clifford D Miles, MD
Article Type: Brief Report | First Published: March 17, 2022
Kidney transplant recipients (KTR) and liver transplant recipients (LTR) are at risk for elevation in serum potassium post-transplant. Patiromer is approved by the Food and Drug Administration for the treatment of hyperkalemia, but there is limited safety and efficacy data for its use in solid organ transplantation. We retrospectively reviewed adult KTR and/or LTR transplanted between October 2015 and September 2019 treated with patiromer. 17 KTR, 13 LTR, and 2 simultaneous liverkidney recipient...